Loading company details...
Beta
Latest Form 4 (Sep 8, 2026): Column Group IV GP, LP (10% Owner): Purchase of 89,200 shares, $1.03M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Column Group IV GP, LP | Purchase | 89,200 | $1.03M |
| Mar 4, 2026 | Michael A. Klobuchar, Chief Operating Officer | Grant/Award | 87,157 | n/a |
| Mar 4, 2026 | Robert Luther Huffines | Grant/Award | 25,873 | n/a |
| Mar 4, 2026 | Kenneth C. Frazier | Grant/Award | 25,873 | n/a |
| Mar 4, 2026 | Roger M. Perlmutter, Chief Executive Officer and Director | Grant/Award | 268,176 | n/a |
| Mar 4, 2026 | Benjamin Bruno Thorner, General Counsel and Chief Business Officer | Grant/Award | 67,044 | n/a |
| Mar 4, 2026 | Roy D. Baynes, Chief Medical Officer | Grant/Award | 134,088 | n/a |
| Mar 4, 2026 | Alfred Lloyd Bowie Jr., Chief Financial Officer | Grant/Award | 67,044 | n/a |
| Feb 10, 2026 | Roger M. Perlmutter, Chief Executive Officer and Director | Conversion | 284,857 | n/a |
| Feb 10, 2026 | Column Group IV GP, LP | Conversion | 1,296,629 | n/a |